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Protective effects of a soy diet in preventing obesity-linked re- Health problems associated with obesity are the devel-
nal disease. opment of insulin resistance and glucose intolerance,
Background. Hypertension, hyperlipidemia, hyperfiltration, hypertension, hypercholesterolemia, and hypertriglycer-hyperinsulinemia, glomerular hypertrophy, and ultimately glo-
idemia [1–13]. In the kidney these are all risk factorsmerular injury and renal failure are associated with obesity in
for the development of glomerular injury and obesity isthe Zucker rat. Evidence from other laboratories suggests that
soy protein might offer renal protection. associated with a marked acceleration of age-associated
Methods. At five weeks of age obese rats were placed on diets glomerular injury [1, 8, 14], particularly in the male rat
containing either soy or casein as a protein source and studied [2]. The obese Zucker rat has a missense mutation ofuntil 24 weeks of age. At six weeks of age and every four weeks
the brain leptin receptors leading to a greater appetitethereafter, 24-hour urine collections were obtained along with
measurements of systolic blood pressure (tail cuff) and blood [15] and these animals develop all of the problems seen
from the tail vein. At the end of the study the kidneys were in human obesity. Glomerular filtration rate (GFR), glo-
fixed and sectioned for histology. merular size, and renal blood flow (RBF) are increased
Results. Both groups gained weight and developed systemic
early in the development of obesity [1, 8, 10, 16, 17].hypertension and hyperinsulinemia at the same rate. Glomeru-
Glomerular capillary blood pressure also is elevated inlar filtration rate (creatinine clearance) also was similar be-
tween groups throughout the study and both groups developed the obese Zucker rat by 22 weeks of age [10, 17]. The
glomerular hypertrophy to the same extent. The development combination of hyperfiltration and glomerular hyper-
of hypertriglyceridemia was actually accelerated in the soy-fed tension is thought to be a primary initiating event forrats compared to the casein-fed animals. The soy diet, however,
glomerular injury [18, 19], but studies in young obesevirtually completely prevented the development of hypercho-
animals (9 to 13 weeks of age) did not find glomerularlesterolemia, primarily low-density lipoprotein (LDL) and/or
very low-density lipoprotein (VLDL) cholesterol, and slowed capillary hypertension [16]. Glomerular hypertrophy
the development of proteinuria and glomerular injury. also has been proposed as an independent risk factor
Conclusions. The data suggest that an important determi-
for the development of glomerular injury [14, 19, 20]. Innant of the protective effects of soy was related to the preven-
addition, elevated serum cholesterol and triglyceridestion of hypercholesterolemia in this model. Other unmeasured
differences between groups, such as differences in glomerular are thought to contribute to, and may initiate, glomerular
capillary blood pressure or the effects of the antioxidant prop- injury in the obese Zucker rat [5, 6, 9, 14, 21]. Attempts
erties of soy components also may have contributed to the to ameliorate the renal pathology associated with obesityprotective effects of soy.
have included dietary as well as pharmacological means.
Soybeans and soy-derived food products contain sig-
nificant amounts of phytoestrogens that are converted
in the intestine to the isoflavones genistein and diadzein
[22]. Genistein and diadzein are structurally similar to
1 Current address: Department of Metabolism and Endocrine Drug
estrogen (17-estradiol [22]) and bind to estrogen recep-Products, Food and Drug Administration, 5600 Fishers Lane, HFD-
510, Rockville, MD 20857, USA. tors, mimicking some of the physiological effects of estro-
gen [23]. The isoflavones derived from soy are thought to
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be beneficial in the prevention of vascular atherosclerosisperlipidemia, overweight, hypercholesterolemia, blood pressure, renal
failure. [24–26] and in one non-obese rat model of renal disease
soy protein-fed animals had lower protein excretion andReceived for publication January 23, 2001
less kidney damage than in animals on a casein diet,and in revised form July 9, 2001
Accepted for publication August 9, 2001 suggesting that soy might provide renal protection as well
[27]. This protection could be related to the observed 2002 by the International Society of Nephrology
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reduction in serum cholesterol levels accompanying a perfusion-fixed via the abdominal aorta at the mean ar-
terial pressure of the animal with 100 mL of 1.25%diet high in soy protein [28, 29]. In addition, soy-based
isoflavone-rich diets as well as chronic isoflavone injec- glutaraldehyde in phosphate-buffered saline (PBS) for
histology following paraffin embedding, sectioning, andtions have been shown to lower blood pressure, an effect
that also might provide renal protection (abstract; Martin staining with either periodic acid Schiff (PAS) or Mas-
son’s trichrome. The right (unfixed) kidney was removedet al, FASEB J 14:A660, 2000) [30, 31]. The current study
was performed to evaluate the effects of a chronic high to determine kidney weight.
soy intake on glomerular injury in the obese Zucker rat.
Analytical techniques
Urine and plasma creatinine concentrations were de-
METHODS
termined by a colorimetric technique (Creatinine Kit
Female obese Zucker rats were obtained at five weeks 555A; Sigma-Aldrich, St. Louis, MO, USA). Prior to de-
of age (Charles River, Raleigh, NC, USA) and randomly termination of plasma creatinine concentration, lipids
assigned to one of two groups (8 rats per group). One were removed from the samples using LipoClear (Stat-
group (designated Ob Casein) was fed a diet containing Spin, Inc., Norwood, MA, USA), since high concen-
casein as the source of protein while a second group trations of plasma lipids interfere with the accurate de-
received a diet containing protein isolated from soy termination of plasma creatinine. Plasma from both the
group (designated Ob Soy). The diets were initially ob- lean and obese Zucker rats was treated in the same
tained from ICN Pharmaceuticals, Inc. (Aurora, OH, manner. Urine protein concentrations were determined
USA) and were provided by a colleague in conjunction by the technique of Fujita, Mori and Kitano [32]. Plasma
with another study and were fed to the animals from insulin concentrations were measured by radioimmuno-
five to nine weeks of age. We subsequently learned that assay (Linco Research, Inc., St. Charles, MO, USA)
both diets contained 14% total protein, an amount less while plasma total cholesterol was determined using a
than that found in most commercial rat chows. We then kit (Sigma-Aldrich kit # 352; Sigma-Aldrich). For high-
increased the protein content to a more normal 23% to density lipoprotein (HDL) cholesterol, plasma was first
maximize the dietary protein effect, since a low protein diluted 1:1 with saline and refrigerated, followed by cen-
diet might be expected to prevent renal disease regard- trifugation at 2,500 g to remove the chylomicron phase.
less of the protein source. Therefore, at nine weeks of HDL cholesterol reagent (Sigma kit 352-4) was then
age the total protein content of both diets was increased added to remove the low-density lipoprotein (LDL) and
using casein as the protein source (25% by weight, 95% very low-density lipoprotein (VLDL) fractions, followed
pure 23% protein) or soy isolate as the protein source by determination of cholesterol (now just HDL) in the
(26.45% by weight, 87% pure  23% protein). These remaining sample. The difference between total choles-
diets (from Purina Test Diets, Richmond, IN, USA) con- terol and HDL cholesterol concentrations was taken as
tained calcium (1.00%), phosphorous (0.6%), sodium the sum of LDL and VLDL cholesterol. Plasma glucose
(0.39%), fat (5.00%) and carbohydrate (59.05%) that concentration was determined using a glucose (Trinder)
were identical to each other. The animals remained on kit (Sigma-Aldrich kit # 315) and plasma triglycerides
the revised diets from 9 to 24 weeks of age when the were determined enzymatically (Sigma-Aldrich kit #
studies were completed. 336).
At six weeks of age (one week after starting on the All kidney sections were coded and blinded to the ex-
ICN diets) and every fourth week thereafter the rats aminer (D.A.M.). Glomerulosclerosis, defined as global
were placed in metabolic cages for 24 hours to measure or segmental capillary collapse with replacement by PAS-
food and water consumption, urine output, and urinary positive material, was determined on each of 100
creatinine and protein concentrations. Systolic blood glomeruli/kidney [1, 33]. Glomeruli exhibiting injury fre-
pressures were then measured by tail cuff plethysmo- quently had attachments to Bowman’s capsule and en-
graph and a small (1 to 2 mL) sample of blood (hemoly- larged capillaries. There was also evidence of tubulo-
sis-free) was obtained from a tail vein for determination interstitial injury including tubular dilation, casts that
of plasma creatinine, cholesterol, triglycerides, glucose, stained with PAS and epithelial damage. The severity
and insulin concentrations. Food was withdrawn from of glomerulosclerosis for each glomerulus was deter-
the animals for five to six hours prior to obtaining blood. mined by locating eyepiece cross hairs over the center
Creatinine clearance, an estimate of GFR, was then de- of the glomerulus and a glomerular sclerosis index (GSi)
termined. At the end of the study the rats were anesthe- was obtained for each glomerulus where GSi equals the
tized with Nembutal (Abbott Laboratories, North Chi- number of quadrants that had evidence of sclerosis (zero
cago, IL, USA), 50 to 60 mg/kg body weight, IP. The to four) [33]. An average glomerulosclerosis index was
femoral artery was cannulated for the determination of then determined for each animal from the100 glomer-
uli observed. The percentage of glomeruli with evidencemean arterial blood pressure. The left kidney was then
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of sclerosis in any of the quadrants was also determined,
as was the percentage of glomeruli that had global sclero-
sis (scarring and collapse of all of the capillaries in the
glomerular tuft). Additional sections were stained with
Masson’s trichrome and an index of tubulointerstitial
fibrosis (TFi) obtained by examining 15 separate cortical
locations on the section at 400magnification and count-
ing the number of quadrants that had blue-stained colla-
gen-containing fibrotic areas in the interstitium (zero to
four) and determining an average TFi per animal [34].
Mean glomerular cross-sectional surface area (AG)
was determined for each rat from measurements on 50
to 100 PAS-stained glomeruli by light microscopy on an
inverted Nikon Diaphot microscope using either the 20
Fig. 1. Food consumption (A) and body weights (B) are plotted as aor 40 objective. The microscope was connected to a
function of age. Values shown are mean  SEM. Symbols are: ()computer by a high-resolution CCD camera (Javelin
casein protein diet; () soy protein diet.
Ultrichip, Los Angeles, CA, USA) and the image pro-
jected on a Sony Trinitron monitor (final screen magnifi-
cation of either 645 or 1290 using 20 or 40 objec-
tives). Using BioScan Optimas (BioScan, Inc., Edmonds, RESULTS
WA, USA) image processing software glomerular cross- Food intake between groups (Fig. 1A) was nearly iden-
sectional area (AG) was measured and the estimated tical (and not significantly different) between groups
glomerular volume (VG) was calculated using established through 18 weeks of age and no adjustments in food
formulas [35]. intake (to maintain equal caloric and protein intake be-
tween groups) were necessary. At 22 weeks of age theStatistical analysis
casein group was eating, on average, a few grams/day
All statistical computations were performed using more than the soy group, but because the difference was
SigmaStat 2.03 (SPSS Inc., Chicago, IL, USA). Data were again not significant we did not reduce the food for the
examined both for normal distribution and homogeneity casein group since they were still essentially pair-fed.
of variance. In some cases data from the Ob Casein and Only at the 24-week collection two weeks later (when
Ob Soy groups are compared to values we previously the study ended) did the casein group have a significantly
obtained in 10 lean Zucker rats (these rats were 60 weeks greater food intake than the soy-fed animals, but by then
old; abstract; Maddox et al, J Am Soc Nephrol 8:622A, the study was over. As seen in Figure 1B, the weekly body
1997). If the data passed the normal distribution and weights were similar between groups and differences in
equal variance tests, the Tukey test for multiple compari- body weight did not reach statistical significance at any
sons was applied. If the raw data did not meet these time point although the soy-fed group actually tended to
criteria the data were log transformed prior to repeated weigh more toward the end of the study than the casein-
measures analysis (log transformation yielded a normal fed animals. One of the Ob Casein rats died at 23 weeks
distribution and homogeneity of variance in all cases of age of renal insufficiency whereas all of the Ob Soy
where applied). For repeated measures analysis, missing rats lived to the end of the study (24 weeks of age).
data points were handled by the program using a general Kidney and heart weights in both the Ob Casein and
linear model. Significant differences between two groups the Ob Soy rats were similar. However, they were sig-
were examined by an unpaired t test if the data passed nificantly greater than previously observed in 60-week-
the normal distribution and equal variance tests. For old lean animals (Table 1) and even greater than the 0.8 g
data that failed these tests, differences between groups estimate for 24-week-old lean female Zucker rats (based
were analyzed by the Mann-Whitney rank sum test. Lin- on other data from our laboratory). In addition, values
ear regression analysis was used to determine the signifi- for glomerular cross-sectional area and glomerular vol-
cance of correlations between parameters. In order to ume were nearly identical between the Ob Casein and
declare that observed differences in the mean values of Ob Soy rats, but values in both groups were significantly
measured parameters between groups were not signifi- greater than in lean animals (Table 1). Thus, the type
cant, we required that the power of the performed test of dietary protein ingested did not appear to affect the
was equal to or greater than 0.80 with alpha  0.05. hypertrophic responses seen in the kidneys and hearts
Statistical significance was accepted only when P  0.05 of obese animals just as body weights were unaffected.
As shown in Figure 2A, systolic blood pressure atand the data are given as mean  SEM.
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Table 1. Kidney and heart weight and glomerular size
Kidney Heart
Glomerular area Glomerular volume
Group weight g lm2 lm3  106
Lean (N10)a 1.070.04 1.120.03 9,217367 1.1380.06
Ob Casein (N7) 1.950.24b 1.420.12b 12,612474b 1.8360.102b
Ob Soy (N8) 1.600.35b 1.440.10b 12,737518b 1.8440.112b
Values are shown as mean  SEM. N represents the number of animals studied for each parameter. Kidney weight is the right (unfixed) kidney weight.
a Lean animals are presented for comparison purposes. This group was part of another study (abstract; Maddox et al, J Am Soc Nephrol 8:622A, 1997, Methods
section).
b P  0.05 vs. values seen in the Lean group; no other comparison reached statistical significance
Fig. 2. Systolic blood pressure (A) and sodium excretion (B) as a
function of age. Values shown are mean  SEM. Symbols are: ()
casein protein diet; () soy protein diet.
all ages was nearly identical between groups, increasing
from 115 to 120 mm Hg at six weeks of age to 140 to
145 mm Hg by 14 weeks of age, and continuing at that
level through the remainder of the study. Averaging the Fig. 3. Glomerular filtration rate (GFR; creatinine clearance) as a func-
tion of age in the casein-fed rats and the soy-fed animals. Values shownvalues obtained for each rat over the entire study from
are mean  SEM. Symbols are: () casein protein diet; () soy pro-6 through 24 weeks of age yielded a mean value of
tein diet.
138.6  2.5 mm Hg in the Ob Casein rats versus 133.1 
2.6 mm Hg for the Ob Soy group (P  0.146). As shown
in Figure 2B, sodium excretion in the Ob Soy rats was
significantly greater at 6 and 10 weeks of age than in the in the Ob Casein group than in the Ob Soy animals and
Ob Casein animals. Beyond 10 weeks of age sodium significant differences between groups persisted for the
excretion rates in the two groups were nearly identical. remainder of the study. As shown in Figure 4B, the
Figure 3 shows the glomerular filtration rate (GFR; cre- differences between groups also were present when pro-
atinine clearance) as a function of age in the two groups. teinuria was corrected for GFR as would be expected
GFR increased in both groups between 6 and 10 weeks given the lack of significant differences in GFR between
of age after the protein content of the diet was switched groups. When corrected for GFR, however, a significant
from 14% to the 23%, but at no time point was GFR difference between groups was also obtained at 6 (but
different between the Ob Casein and the Ob Soy rats. not 10) weeks of age in addition to the other time points.
Repeated measures analysis of variance indicated that As shown in Figure 5A, neither group of animals de-
veloped severe hyperglycemia and differences in plasmathere was a continual increase in urinary protein excre-
tion with age in both the Ob Casein and Ob Soy groups glucose concentrations between groups did not reach
statistical significance. Associated with the developmentbetween 6 and 24 weeks of age (Fig. 4A). By 14 weeks of
age, however, protein excretion was significantly greater of obesity, plasma insulin levels at 10 weeks of age were
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Fig. 4. Proteinuria (UProtV) as a function of age (A) and proteinuria cor-
rected for GFR (UProtV/GFR, B). Values shown are mean SEM. Sym-
Fig. 6. Plasma cholesterol concentrations (A) and plasma triglyceridesbols are: () casein protein diet; () soy protein diet.
(B), as a function of age. Symbols are: LDL and VLDL cholesterol
levels in the () casein- and () soy-fed rats; HDL cholesterol levels
in () casein- and () soy-fed rats. Values shown are mean  SEM.
cantly) lower in the soy-fed rats than in the casein-fed
animals. Plasma triglyceride levels for the two groups
are shown in Figure 6B. Repeated measures analysis of
variance indicated that plasma triglycerides increased
with time in the Ob Casein group, eventually reaching
values averaging 1400 mg/dL by the end of the study,
but the increase did not begin to occur until 18 weeks
of age. Plasma triglyceride concentration in the Ob Cas-
ein rats actually fell between 6 weeks of age (258  34
mg/dL) and 10 weeks of age (83  8 mg/dL, P  0.05).
By contrast, plasma triglycerides in the Ob Soy group
were already significantly elevated above the six-week
values by 10 weeks of age with values significantly ex-Fig. 5. Plasma glucose concentration (A), plasma insulin concentration
ceeding those of the Ob Casein group at 10, 14, and 18(B), each plotted as a function of age. Values shown are mean  SEM.
Symbols are: () casein protein diet; () soy protein diet. weeks of age (P  0.005 at each time point). There was
a small but statistically significant difference between
groups in the low levels of plasma triglycerides observed
at six weeks of age after one week on the diets withsignificantly greater in both groups than they were at six
values in the Ob Casein group exceeding those in the Obweeks of age (Fig. 5B). Plasma insulin levels were similar
Soy group (258  34 mg/dL vs. 162  18 mg/dL, re-between groups at all time points and the values were
spectively, P  0.025). As can be seen, that quickly re-markedly elevated compared to those we previously ob-
versed itself by ten weeks of age and the soy-fed ratsserved in lean female Zucker rats at similar ages (1.0 ng/
actually had much greater triglyceride levels than themL at all time points in lean animals; unpublished ob-
Ob Casein group during the time that the latter groupservations).
was developing significant proteinuria (Fig. 4).As seen in Figure 6A, plasma LDL  VLDL choles-
As shown in Figure 7A, there was a significant correla-terol levels (the difference between total and HDL cho-
tion between plasma total cholesterol and body weightlesterol) increased with age in the Ob Casein group yield-
over the period of study in the Ob Casein group [cho-ing values from ages 10 to 24 weeks that were all sig-
lesterol  0.845 (body weight)  30, r  0.70, P  0.001nificantly greater than at 6 weeks. Values at 24 and 22
for the 47 individual measurements obtained during theweeks of age were greater than those at 10 weeks while
course of the study]. By contrast, the correlation betweenvalues at 24 weeks were also greater than at 14 weeks
plasma cholesterol levels and body weight did not reachof age. The Ob Soy group, by contrast, exhibited less of
statistical significance in the Ob Soy group. As shown inan increase in plasma LDL  VLDL cholesterol with
Figure 7B, there was a highly significant correlation be-age. HDL cholesterol levels remained constant with age
in both groups, but tended to be slightly (but signifi- tween 24-hour urinary protein excretion and plasma
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Fig. 7. Total plasma cholesterol concentration is shown as a function
of body weight (A). The values plotted are the mean values obtained
for each parameter and each group at 6, 10, 14, 18, 22 and 24 weeks
of age. (B) Proteinuria (UProtV) is plotted as a function of plasma
cholesterol using final individual animal values obtained at the end of
the study.
Fig. 8. Protein excretion (UProtV) at the end of the study as a function
LDLVLDL cholesterol at the time of the last urine col- of glomerular injury (glomerular sclerosis index). Symbols are: ()
casein protein diet; () soy protein diet. y  908x  140; r  0.829;lection. There was no correlation between plasma triglyc-
P  0.001.erides and urinary protein excretion such as that observed
between plasma cholesterol and protein excretion.
Differences in the percentage of glomeruli with sclero-
sis in the Ob Casein rats (45.0  6.6%) and the Ob Soy death from renal insufficiency. We recently found that
rats (32.4  4.2%) did not reach statistical significance. limiting dietary food intake in these animals to levels
However, in accord with the differences in proteinuria consumed by their lean litter mates can completely pre-
between groups, the glomerular sclerosis index (which vent glomerular injury in these animals when food re-
provides a sensitive index of the total magnitude of scle- striction is initiated early in life (abstract; Maddox et al,
rosis, see Methods section) was significantly greater in ibid). The present study examined whether alterations
the Ob Casein rats compared to the Ob Soy group in the type of dietary protein (animal-derived casein vs.
(0.84  0.12 and 0.52  0.09, respectively, P  0.05). As plant-derived soy protein) would modify the progression
shown in Figure 8, when the data from both groups were of renal disease in the obese animal.
combined a highly significant correlation between the There are several reasons to hypothesize that soy pro-
sclerosis index and proteinuria was observed [protein- tein might offer some renal protection. Soy protein, per-
uria  908  (sclerosis index)  140; r  0.829, P  haps acting through the phytoestrogens found in it, has
0.001]. The difference between the index of tubulointer- been shown to reduce serum cholesterol levels similar
stitial fibrosis (TFi) obtained from Masson trichrome- to that induced by estrogen [28, 29] and to aid in the pre-
vention of vascular atherosclerosis [24–26]. The amino acidstained sections in the casein-fed rats (1.80  0.37) and
composition of soy, high in arginine and glycine, alsothat in the soy-fed rats (0.98 0.17) did not reach statis-
may induce a low postprandial insulin/glucagon ratio thattical significance (P 0.102). For all animals, a significant
may be associated with the low serum cholesterol levelscorrelation was observed between kidney weight and the
[36]. Renal blood flow was found to be lower in animalsTFi, with the greatest degree of interstitial fibrosis (value
on soy protein than that observed in animals on a caseinof 3.6) occurring in a casein-fed animal that also had the
diet and this may offer protection [27]. Soy-based isofla-largest kidney (3.25 g) and most number of tubular casts
vone-rich diets as well as chronic isoflavone injectionsof any rat.
have been shown to lower blood pressure (abstract; Mar-
tin et al, ibid) [30, 31]. If this translates into a reduction
DISCUSSION in glomerular capillary hydraulic pressure, the combina-
The obese Zucker rat develops hyperinsulinemia, hy- tion of reduced glomerular blood flow and hydraulic pres-
pertension, hypercholesterolemia, hypertriglyceridemia, sure also may offer protection against glomerular injury
[18, 19]. Soy protein in normal rats may improve periph-hyperfiltration, glomerular hypertrophy, and ultimately
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eral insulin sensitivity and lower fasting glucose and insu- zyme activity [44]. Future studies are needed to answer
this question.lin levels, again potentially offering a mechanism for renal
protection [37]. Finally, the antioxidant properties of soy Glomerular hypertrophy has been proposed to be an
independent risk factor for the progression of renal dis-isoflavones and other components of soy might offer
protection much like that of estrogen [38]. ease [14, 18, 19] and glomerular hypertrophy has been
observed in the obese Zucker rat [17]. In the presentPrevious studies have examined the renal protective
effects of soy. In a non-obese rat model of renal disease study, however, the soy diet provided protection against
the progression of glomerular injury (demonstrated bysoy protein-fed animals had lower protein excretion and
less kidney damage than in animals on a casein diet both reduced proteinuria and less evidence of glomerulo-
sclerosis) without preventing the glomerular hypertro-[27]. Patients in one randomized crossover study with a
variety of causes of nephrotic syndrome received either phy associated with obesity.
In the present study we did not observe any long-terma soy protein diet or soy protein with fish oil (5 g/day)
[39]. On the soy protein diet there was a reduction in antihypertensive effect of soy in the obese Zucker rat
although there was a tendency for systolic blood pressurealbuminuria and blood lipid levels, and adding the fish
oil had no further benefit in preventing glomerular injury to be lower in the soy-fed rats by 5 mm Hg over the
course of the study (Fig. 2). In other studies soy-based[39]. In one study of obese patients with type II diabetes
(5 years), however, consumption of a soy-based diet for isoflavone-rich diets as well as chronic isoflavone injec-
tions have been shown to lower blood pressure (abstract;eight weeks reduced serum cholesterol and triglycerides
compared to patients on a beef diet, but had no effect Martin et al, ibid) [30, 31]. Our data suggest that at best
any effects of soy on blood pressure in the obese Zuckeron GFR or proteinuria [40]. Soy has been shown to
reduce glomerular injury in the Fisher rat [41, 42], but rat are small. Others have noted that soy or soy products
increase sodium excretion perhaps due to (1) inhibitionno studies have yet examined whether soy would offer
renal protection in the obese Zucker rat. of sodium transport in the thick ascending limb of the
loop of Henle (abstract; Martinez, Second InternationalOur study indicated that the rate of progression of
glomerular injury in the obese Zucker rat was blunted Symposium on the Role of Soy in Preventing and Treating
Chronic Disease 18, 1996), (2) increased release of atrialby a soy protein diet compared to a casein diet as evi-
denced by (1) a delay in the development of proteinuria natriuretic peptide from the myocardium [45], and (3)
inhibition of angiotensin II production through effectsand (2) significantly less glomerular injury at 24 weeks
of age as evidenced by a lower glomerulosclerosis index. on angiotensin-converting enzyme [44]. In accord with
these findings, in the present study sodium excretion at 6This occurred despite a comparable food intake and
weight gain throughout the study. In addition there were and 10 weeks of age was significantly greater in the soy-fed
rats than in the casein-fed animals despite identical so-no differences in fasting plasma insulin or glucose con-
centrations between groups at any point during the study. dium intake between groups (Fig. 2), but this difference
did not yield significant differences in blood pressure.We did not examine postprandial insulin or glucagon
levels. In other animal models soy protein has been In addition to possible effects on blood pressure, soy
isoflavones have been shown to reduce plasma LDL cho-shown to preserve glomerular morphology, prevent pro-
teinuria, and prevent glomerular hyperfiltration, the lat- lesterol levels to a similar extent as that produced by
estrogen [28]. Elevated serum lipids are thought to con-ter effect offering a potential mechanism for the protec-
tive effect of soy [18, 19, 27] and it has been shown that tribute to glomerular injury in the obese Zucker rat [9],
perhaps mediated, in part, by elevations in LDL choles-consumption of a soy-protein meal does not produce the
hyperfiltration seen with animal-based proteins such as terol. In the present study the soy diet almost completely
prevented the increase in cholesterol levels observed intuna [43]. In our study there were no differences in glo-
merular filtration rate (creatinine clearance) between the the rats on a casein-based diet. As shown in Figure 6,
this was almost entirely the result of prevention in a riseanimals fed soy versus those fed casein at any point in
the study. This finding is similar to that observed by in plasma LDL and/or VLDL cholesterol by the soy diet.
Data obtained by Gades and co-workers indicated thatAnderson and coworkers in patients with type II diabetes
in which GFR was similar between subjects on an animal there was a closer correlation between changes in plasma
triglycerides and the development of glomerular injuryprotein diet versus a soy protein diet [40]. However, we
cannot say that there was no difference in glomerular in the obese Zucker rat than between plasma cholesterol
and injury when obese Zucker rats that were restricted inhemodynamics between groups in our study, since we
did not directly measure glomerular capillary pressure food intake (and hence didn’t develop glomerular injury)
were switched to ad libitum feeding on a soy-based dietand glomerular plasma flow rate. It is possible that glo-
merular hydraulic pressure was elevated in the casein-fed [6]. They suggested that hypercholesterolemia was the
consequence rather than the cause of the nephrotic syn-animals and was reduced in the animals fed soy protein,
perhaps through inhibition of angiotensin converting en- drome in the obese Zucker rat and that hypertriglyceri-
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demia was the factor that led to glomerular injury. We This study confirms that the type/source of dietary pro-
tein can play an important role in the development ofalso observed that obese Zucker rats develop hypertri-
glyceridemia as well as hypercholesterolemia and glo- renal injury in the obese animal. The protective effect
of soy versus casein did not appear to be related tomerular injury when fed ad libitum with a diet high in
soy (abstract; Maddox et al; ibid). Furthermore, when differences in blood pressure, glomerular filtration rate,
caloric or electrolyte intake, the degree of glomerularthose obese rats were restricted in food intake to equal
that consumed by lean animals, glomerular injury was hypertrophy, hypertriglyceridemia, blood glucose levels,
or the degree of hyperinsulinemia. Animals on the soyprevented (when food restriction was imposed early in
life) or possibly reversed (when imposed late in life) and diet had significantly less hypercholesterolemia, particu-
larly LDL and/or VLDL cholesterol, than the rats on athese effects were correlated with a reduction in plasma
triglycerides. In the present study we found that hyper- casein-rich diet together with a significant blunting of the
rate of development of proteinuria and glomerular in-cholesterolemia preceded the development of protein-
uria in the Ob Casein rats (cf. Figs. 4 and 6). jury, indicating, as has been seen in other studies, that
protection against high serum lipids can offer one meansThe development of glomerular injury indicated by in-
creased proteinuria in the Ob Casein animals preceded of preserving renal function. The protective effects against
glomerular injury did not appear to be as effective asthe development of hypertriglyceridemia but followed the
development of hypercholesterolemia, suggesting that we previously observed with dietary food restriction to
levels consumed by lean litter mates (abstract; Maddoxplasma cholesterol levels might be more important than
triglyceride levels in initiating glomerular injury. Indeed, et al, ibid). The mechanisms for the protective effects of
soy, in future studies, might be discerned by combiningthe Ob Soy rats had markedly elevated triglyceride levels
even by ten weeks of age, yet proteinuria was delayed studies of the renal hemodynamic effects of a soy-based
diet versus casein with an examination of alterations inin these animals compared to the Ob Casein group. In
a separate study, Gades and coworkers observed that gene expression of those cytokines and chemokines that
might be involved in glomerular and tubular injury, suchestrogen administered to ovariectomized (OVX) female
obese Zucker rats accelerated the development of glo- as with the aid of DNA microarray technology.
merular injury when compared to sham-operated ani-
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